We are live on
!
Find out more
MDSL
M.D. Sass LLC Portfolio holdings
AUM
$1.32B
1-Year Est. Return
16.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.12%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$424M
AUM Growth
-$8.4M
(-1.9%)
Cap. Flow
-$13.2M
Cap. Flow
% of AUM
-3.1%
Top 10 Holdings %
Top 10 Hldgs %
42.34%
Holding
57
New
3
Increased
16
Reduced
32
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$15.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$13M |
| 3 |
Sony
SONY
|
+$12.7M |
| 4 |
Charles River Laboratories
CRL
|
+$7.24M |
| 5 |
Amazon
AMZN
|
+$1.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$14.5M |
| 2 |
Vulcan Materials
VMC
|
+$10.4M |
| 3 |
Air Products & Chemicals
APD
|
+$8.16M |
| 4 |
Take-Two Interactive
TTWO
|
+$6.66M |
| 5 |
LKQ Corp
LKQ
|
+$5.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.37% |
| 2 | Technology | 17.07% |
| 3 | Healthcare | 11.67% |
| 4 | Communication Services | 11.53% |
| 5 | Financials | 10.09% |
Similar funds
LCS
CC
CP
IEFM
GSEP
TIM
MCM
HCM
M.D. Sass LLC's Q3 2019 Portfolio in Review
As of Q3 2019, M.D. Sass LLC held 57 positions worth $424M, down 1.9% from $432M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
M.D. Sass LLC withdrew a net $13.2M in Q3 2019, closing 4 positions and reducing 32 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
Against the trend, M.D. Sass LLC opened a new position in Quest Diagnostics worth $16.5M.
- M.D. Sass LLC's largest Q3 2019 buy was Quest Diagnostics: 154,057 shares worth $16.5M.
- M.D. Sass LLC added most to Charles River Laboratories in Q3 2019, an estimated $7.24M increase.
- M.D. Sass LLC's biggest Q3 2019 reduction was Vulcan Materials, cutting an estimated $10.4M.
- M.D. Sass LLC fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q3 2019, selling an estimated $14.5M.
- M.D. Sass LLC's ten largest holdings make up 42% of its $424M portfolio in Q3 2019.
- M.D. Sass LLC opened 3 new positions and closed 4 in Q3 2019.
- M.D. Sass LLC's portfolio value fell 1.9% quarter-over-quarter to $424M.
Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.